Guangzhou Sanfu New Materials Technology (688359.SH) repurchased 74,000 shares for the first time, at a cost of RMB4.5797 million.

20:06 10/11/2026

Sanfu New Materials Technology (688359.SH) announced that on November 10, 2026, the company implemented its first share repurchase through the centralized bidding trading method via the Shanghai Stock Exchange trading system, repurchasing 74,000 shares, accounting for 0.07% of the company's total share capital. The highest repurchase price was RMB62.73 per share and the lowest was RMB61.13 per share, with total funds paid amounting to RMB4.5797 million (excluding stamp duty, trading commissions and other transaction fees).

Guangzhou Sanfu New Materials Technology (688359.SH) announced that on November 10, 2026, the company implemented its first share repurchase through the centralized bidding trading method via the Shanghai Stock Exchange trading system, repurchasing 74,000 shares, accounting for 0.07% of the company's total share capital. The highest repurchase price was RMB62.73 per share, and the lowest was RMB61.13 per share, with a total amount paid of RMB4.5797 million (excluding stamp duty, trading commissions, and other transaction fees).

JINCHUAN INTL (02362): In the first three quarters, the mining business produced 57,929 tonnes of copper content in electrolytic copper and copper concentrate, an increase of approximately 31.6% year-on-year.

SAINT BELLA GP (02508) repurchased 25,000 shares on November 10 for HK$61,400.

SIMCERE PHARMA (02096): SIM0725 (CD122) Receives Drug Clinical Trial Approval Notice Issued by the National Medical Products Administration

SAINT BELLA GP (02508) repurchased 25,000 shares on November 10 for HK$61,400.

SIMCERE PHARMA (02096): SIM0725 (CD122) Receives Drug Clinical Trial Approval Notice Issued by the National Medical Products Administration